What is the non‑operative management of a bimalleolar ankle fracture in a patient aged in their late 80s or older who is not a surgical candidate?

Non-Operative Management of Bimalleolar Ankle Fractures in Patients ≥80 Years Who Are Not Surgical Candidates

For non-surgical candidates in their late 80s with bimalleolar ankle fractures, immobilize in a short leg cast or walking boot with early weight-bearing as tolerated after achieving closed reduction, combined with immediate initiation of osteoporosis treatment and multidisciplinary orthogeriatric care.

Immediate Fracture Management

Closed Reduction and Immobilization

Attempt closed reduction to achieve anatomic alignment (displacement ≤2 mm is acceptable). If stable reduction is achieved, immobilize in a short leg cast or walking boot 1, 2. The key is maintaining reduction through serial radiographs during the first 6 weeks—this is where non-operative treatment fails if not monitored closely 2.

Critical pitfall: Non-operative treatment of displaced fractures without achieving and maintaining anatomic reduction leads to poor outcomes. You must obtain post-reduction radiographs and repeat imaging at 1-2 weeks to confirm maintenance of reduction 2, 3.

Weight-Bearing Protocol

Initiate early weight-bearing as tolerated within the first 1-2 weeks, rather than traditional 6-8 weeks of non-weight-bearing 1. This is crucial for this age group because:

• Early weight-bearing significantly improves quality of life (SF-12 scores: 64.9 vs 52.9 at 6 weeks, p<0.001) 1
• Functional independence is better preserved (Barthel Index: 64.2 vs 54.3 at 6 weeks, p<0.001) 1
• No increase in complications compared to non-weight-bearing 1
• Prevents the catastrophic loss of autonomy that occurs with prolonged bed rest in octogenarians 4

The evidence specifically demonstrates this approach works for Weber B bimalleolar fractures in patients with mean age 82-83 years 1.

Concurrent Medical Management

Osteoporosis Treatment - Start Immediately

Begin pharmacological osteoporosis treatment without waiting for DXA scan 5. For elderly patients with fragility fractures and immobility/comorbidities, anti-osteoporotic treatment can be initiated even without bone density testing 5.

First-line agents 5:

• Alendronate or risedronate (oral bisphosphonates) - preferred due to low cost, tolerability, and extensive clinical experience
• Alternative options if oral intolerance, dementia, malabsorption, or non-compliance exists:
  • Zoledronic acid (IV annually)
  • Denosumab (subcutaneous every 6 months)

Mandatory supplementation 5:

• Vitamin D 800 IU daily (reduces non-vertebral fractures by 15-20% and falls by 20%)
• Calcium 1000-1200 mg daily (dietary plus supplementation if needed)

Avoid high-pulse vitamin D dosing as it increases fall risk 5.

Orthogeriatric Approach

Implement a multidisciplinary orthogeriatric team immediately 5. This is not optional—frail elderly patients with major fractures require this approach to optimize outcomes 5. Address:

• Comorbidity optimization: diabetes control, cardiovascular status, nutritional status
• Fall risk assessment and prevention: home safety evaluation, assistive devices
• Pain management: adequate analgesia to enable mobilization
• Physical therapy: early mobilization to prevent deconditioning

Monitoring Protocol

Radiographic Surveillance

• Week 0: Post-reduction films to confirm acceptable alignment
• Week 1-2: Repeat radiographs to detect early displacement
• Week 6: Assess maintenance of reduction and healing progress
• Week 12: Confirm union

If displacement occurs (>2 mm), reassess surgical candidacy or accept malunion if patient remains non-surgical candidate 2.

Clinical Follow-up

Monitor for:

• Skin breakdown inside cast/boot (high risk in elderly with fragile skin) 4
• Deep vein thrombosis (consider prophylaxis based on mobility status)
• Loss of reduction requiring intervention
• Functional decline requiring increased support

Expected Outcomes and Counseling

Realistic Expectations

With proper non-operative management of anatomically reduced bimalleolar fractures:

• Long-term outcomes can be excellent (average OMAS 98/100 at 20 years) 2
• Most patients remain minimally symptomatic with mild or no degenerative changes 2
• Early weight-bearing improves quality of life without increasing complications 1

When Non-Operative Treatment Fails

The main risks are:

• Secondary displacement (requires close monitoring in first 6 weeks) 2, 4
• Skin lesions inside cast leading to infection 4
• Loss of autonomy if immobilization is prolonged 4

Mortality considerations: Recognize that mortality in this population ranges 10-27%, with higher rates in non-operative and frail populations 6. The goal is preserving autonomy and quality of life, not just fracture union.

Special Considerations

Contraindications to Non-Operative Treatment

Even in non-surgical candidates, consider external fixation or minimal fixation if:

• Unable to achieve or maintain closed reduction
• Catastrophic soft tissue conditions
• Severe instability that prevents any mobilization 4

Charcot Neuro-osteoarthropathy

Critical to exclude: If diabetic neuropathy present, standard treatment will fail. These patients require completely different management 7.